Abstract
Osteoporosis is becoming a major public health problem in Asian countries, with a rapid increase in osteoporotic fractures projected as urbanization increases, particularly in China. The purpose of this post hoc analysis was to assess the effects of 12 months of treatment with raloxifene on the incidence of clinical fractures in postmenopausal Asian women, compared to a placebo, by combining two independently designed studies (one Japanese study and one Chinese study). A total of 488 women, 284 in Japan and 204 in China were included in the analysis. Baseline characteristics (mean ± SD) for the Japanese and Chinese women were: age, 64.8 ± 6.3 years and 65.3 ± 6.0 years; body mass index, 21.8 ± 2.8 kg/m2 and 23.0 ± 2.9 kg/m2; and prevalent vertebral fractures, 26.4% and 13.7%, respectively. In both studies, the clinical vertebral and nonvertebral fractures were confirmed by radiographs or clinical reports at a central research facility. From the two combined studies, the incidence of new clinical vertebral fractures was significantly lower in the raloxifene 60 mg/day (RLX60) group (0 out of 194, P = 0.01) and in the pooled raloxifene group (those taking 60 mg/day and those taking 120 mg/day) (0 out of 289, P = 0.002), compared with the placebo group (7 out of 199, 3.5%). The pooled raloxifene group, as well as the RLX60 group, also had a significantly lower incidence of any new clinical fracture (P = 0.001 and P = 0.01, respectively) compared to the placebo group. In conclusion, raloxifene treatment at 60 mg/day for 1 year resulted in a significant reduction in the risk of new clinical vertebral fractures and any new clinical fracture in postmenopausal Asian women with osteoporosis.
Similar content being viewed by others
References
H Orimo T Hashimoto K Sakata N Yoshimura T Suzuki T Hosoi InstitutionalAuthorNameGeneral Research Committee for Prevention of Osteoporosis, Ministry of Health and Welfare, Tokyo Metropolitan Geriatric Hospital, Japan (2000) ArticleTitleTrends in the incidence of hip fracture in Japan, 1987–1997: the third nationwide survey J Bone Miner Metab 18 126–131 Occurrence Handle10783845 Occurrence Handle1:STN:280:DC%2BD3c3ksVCgsw%3D%3D Occurrence Handle10.1007/PL00010636
EG Lufkin M Wong C Deal (2001) ArticleTitleThe role of selective estrogen receptor modulators in the prevention and treatment of osteoporosis Rheum Dis Clin North Am 27 163–185 Occurrence Handle11285993 Occurrence Handle1:STN:280:DC%2BD3MzpsVCmtg%3D%3D Occurrence Handle10.1016/S0889-857X(05)70192-7
M Maricic JD Adachi S Sarkar W Wu M Wong KD Harper (2002) ArticleTitleEarly effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis Arch Intern Med 162 1140–1143 Occurrence Handle12020184 Occurrence Handle1:CAS:528:DC%2BD38XksFWksbw%3D Occurrence Handle10.1001/archinte.162.10.1140
Y Qu M Wong D Thiebaud JL Stock (2005) ArticleTitleThe effect of raloxifene therapy on the risk of new clinical vertebral fractures at 3 and 6 months: a secondary analysis of the MORE trial Curr Med Res Opin 21 1955–1959 Occurrence Handle16368046 Occurrence Handle1:CAS:528:DC%2BD28XhtF2ju74%3D Occurrence Handle10.1185/030079905X75032
H Morii Y Ohashi Y Taketani M Fukunaga T Nakamura A Itabashii S Sarkar K Harper (2003) ArticleTitleEffect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial Osteoporos Int 4 793–800 Occurrence Handle10.1007/s00198-003-1424-1 Occurrence Handle1:CAS:528:DC%2BD3sXosFWrsLo%3D
J Liu H Zhu Q Huang Z Zhang H Li Y Qin Y Zhang D Wei J Lu H Liu X Chen Y Liu A Ekangaki J Southby A Diez-Perez (2004) ArticleTitleEffects of raloxifene (RLX) on bone mineral density (BMD), and serum lipids in Chinese postmenopausal women with osteoporosis Chin Med J 117 1029–1035 Occurrence Handle15265377 Occurrence Handle1:CAS:528:DC%2BD2cXnt1Oisbc%3D
HK Genant M Jergas L Palermo M Nevitt RS Valentin D Black SR Cummings (1996) ArticleTitleComparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis J Bone Miner Res 11 984–996 Occurrence Handle8797120 Occurrence Handle1:STN:280:DyaK28zptVShtA%3D%3D Occurrence Handle10.1002/jbmr.5650110716
PD Delmas KE Ensrud JD Adachi KD Harper S Sarker C Gennari JY Reginster HAP Pols RR Recker ST Harris W Wu HK Genant DM Black R Eastell InstitutionalAuthorNamefor the Multiple outcomes of raloxifene evaluation (MORE) investigators (2002) ArticleTitleEfficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial J Clin Endocrinol Metab 87 3609–3617 Occurrence Handle12161484 Occurrence Handle1:CAS:528:DC%2BD38XmtF2gsLg%3D Occurrence Handle10.1210/jc.87.8.3609
B Ettinger DM Black BH Mitlak RK Knickerbocker T Nickelsen HK Genat C Christiansen PD Delmas JR Zanchetta J Stakkestad CC Glüer K Krueger FJ Cohen S Eckert KE Ensrud LV Avioli P Lips SR Cummings InstitutionalAuthorNamefor the Multiple outcomes of raloxifene evaluation (MORE) investigators (1999) ArticleTitleReduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial JAMA 282 637–645 Occurrence Handle10517716 Occurrence Handle1:CAS:528:DyaK1MXlvVKqurg%3D Occurrence Handle10.1001/jama.282.7.637
PD Delmas HK Genant GG Crans JL Stock M Wong E Siris JD Adachi (2003) ArticleTitleSeverity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial Bone 33 522–532 Occurrence Handle14555255 Occurrence Handle1:STN:280:DC%2BD3svnslSgsw%3D%3D Occurrence Handle10.1016/S8756-3282(03)00241-2
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Nakamura, T., Liu, J., Morii, H. et al. Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis. J Bone Miner Metab 24, 414–418 (2006). https://doi.org/10.1007/s00774-006-0702-3
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00774-006-0702-3